W43 (Rosiglitazone Maleate 8 mg (base))
Pill with imprint W43 is Red, Elliptical / Oval and has been identified as Rosiglitazone Maleate 8 mg (base). It is supplied by West-ward Pharmaceutical Corp..
Rosiglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Rosiglitazone 8 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for W43
Rosiglitazone Maleate
- Imprint:
- W43
- Strength:
- 8 mg (base)
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Thiazolidinediones
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- West-ward Pharmaceutical Corp.
- National Drug Code (NDC):
- 00143-9975
More about rosiglitazone
- Rosiglitazone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 8 Reviews
- Drug class: thiazolidinediones
Consumer resources
Other brands: Avandia
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
